Conference
Strategic Product and Portfolio Management for Generics 2016
Management · Pharmaceuticals
Key numbers
- Editions on record
- 2first in 2016
About Annual Portfolio Management Strategies for Biosimilars and Generics
Foster Performance and Growth in Generics Business Models, Invest in Differentiated Products and Innovation Strategies, Enhance Market Access and Customers Understanding to Benefit from New Development Opportunities Attending this Premier marcus evans Conference will Enable You to: • Gain practical methodology to decision making in generic portfolio • Improve internal capabilities to deal with multiple products • Ensure alignment between country and global portfolio levels • Drive continual Improvement to refine and enhance launch • Build a joint partnership to expand in new markets • Entering into value-added generics potential • Investing in biosimilars to capture future growth
From our listing of this edition. Details may have changed since.
Editions
Past editions from the bvents archive (2008–2019) and organiser figures where they were published.